Nordea Investment Management’s NovoCure NVCR Stock Holding History

Nordea Investment Management’s Portfolio NVCR Stock Details NVCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-5,347	Closed	-$220K	–	968
2023 Q2	$220K	Hold	5,347	–	–	﹤0.01%	946
2023 Q1	$317K	Sell	5,347 -149	-3%	-$11.9K	﹤0.01%	935
2022 Q4	$393K	Sell	5,496 -973	-15%	-$73.2K	﹤0.01%	909
2022 Q3	$503K	Buy	6,469 +1,014	+19%	+$79.1K	﹤0.01%	894
2022 Q2	$383K	Sell	5,455 -533	-9%	-$40.2K	﹤0.01%	920
2022 Q1	$500K	Hold	5,988	–	–	﹤0.01%	893
2021 Q4	$477K	Hold	5,988	–	–	﹤0.01%	925
2021 Q3	$695K	Hold	5,988	–	–	﹤0.01%	880
2021 Q2	$1.33M	Buy	5,988 +2,074	+53%	+$403K	﹤0.01%	745
2021 Q1	$512K	Hold	3,914	–	–	﹤0.01%	903
2020 Q4	$677K	Buy	+3,914	New	+$536K	﹤0.01%	817

Other funds holding NVCR

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Voloridge Investment Management Jupiter, Florida $25B AUM 28.08% 1-Year Est. Return

Nordea Investment Management's NVCR Position: Q3 2023 in Review

Nordea Investment Management sold out of NovoCure (NVCR) in Q3 2023, closing a stake of 5,347 shares — an estimated $220K sold.

Nordea Investment Management first reported a position in NVCR in Q4 2020 and held it in 11 quarters. The position peaked at $1.33M in Q2 2021. 226 funds tracked by Wall St. Rank hold NVCR as of Q3 2023.

Nordea Investment Management reported no remaining NovoCure position as of Q3 2023 after selling out during the quarter.
Nordea Investment Management sold 5,347 NovoCure shares in Q3 2023, an estimated $220K.
Nordea Investment Management first reported a position in NovoCure in Q4 2020 and held it in 11 quarters.
Nordea Investment Management's NovoCure position peaked at $1.33M in Q2 2021.
226 funds tracked by Wall St. Rank held NovoCure as of Q3 2023.

Based on Nordea Investment Management's 13F filing for Q3 2023, filed 13 Nov 2023.